Aller au contenu principal
Profil bibliographique

Diana Altshuler

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

46Publications signalées
789Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Anesthesia and Sedative AgentsCOVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentMechanical Circulatory Support DevicesIntensive Care Unit Cognitive Disorders

Les publications récentes

2024 article OpenAlex

Elevated Anti-Xa in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration

Tatiana Weinstein, Diana Altshuler, Elyse LaFond, Alyson Katz

Venous thromboembolism prophylaxis with subcutaneous unfractionated heparin or low molecular weight heparin is a common practice in hospitalized patients. Typically, prophylactic doses of these medications have poor bioavailability and thus do not reach therapeutic serum concentrations. However, in certain circumstances, heparin binding …

us (code pays fourni par la source)

2 citations Journal of Pharmacy Practice
Accès ouvert 2023 article OpenAlex

Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure

Juri Chung, Shari B. Brosnahan, Shahidul Islam, Diana Altshuler et autres

PURPOSE: Tocilizumab has been shown to decrease mortality when used concomitantly with steroids in COVID-19 with 8 mg/kg (max 800 mg) being the standard dose. Our study sought to assess whether a low dose (400 mg) shows similar benefit compared to a …

us (code pays fourni par la source)

1 citation Journal of Critical Care
2022 article OpenAlex

1108: LOW-DOSE VERSUS HIGH-DOSE TOCILIZUMAB IN COVID-19 PATIENTS WITH HYPOXIC RESPIRATORY FAILURE

Wai Man Wang, Xian Jie Chen, Juri Chung, Wai Kin Li et autres

Introduction: Tocilizumab has been shown to decrease mortality when used concomitantly with steroids in COVID-19. Tocilizumab dose of 8 mg/kg (max: 800 mg), stemmed from the RECOVERY trial, has been the standard dose for COVID. Due to a drug shortage of tocilizumab, …

us (code pays fourni par la source)

0 citations Critical Care Medicine
2022 article OpenAlex

804: SUGAMMADEX (BRIDION) MEDICATION USE EVALUATION IN A 591-BED TEACHING HOSPITAL

Matt Niewinski, Shan Wang, Diana Altshuler

Introduction: Sugammadex is a modified gamma cyclodextrin encapsulating agent that reverses the action of neuromuscular blocking agents [NMBA] rocuronium and vecuronium. It is one of our institutional’ s high cost medications. As compared to neostigmine, sugammadex has lower incidence of bradycardia, post-operative …

us (code pays fourni par la source)

0 citations Critical Care Medicine
2022 article OpenAlex

481: INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR SEVERE OR FULMINANT CLOSTRIDIUM DIFFICILE INFECTION

Olivia Nuti, Diana Altshuler, Serena Arnouk, Alyson Katz et autres

Introduction: Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Salvage therapy may include IVIG, fecal microbiota transplant (FMT) or colectomy. There is limited data regarding the effectiveness of IVIG for CDI (43-65%) or optimal dosing strategies. Methods: This is …

us (code pays fourni par la source)

2 citations Critical Care Medicine
Accès ouvert 2022 article OpenAlex

Efficacy and safety of propofol dosing based on ideal body weight vs. actual body weight: a retrospective cohort study

Ilana Gimelbrand, Cristian Merchan, Prachi Bhatt, Chanie Wassner et autres

Background: Various weight-based strategies using actual, ideal, adjusted, and lean body weights (LBWs) have been studied for propofol dosing finding that propofol is better related to LBW as opposed to actual body weight (ABW). However, the most common dosing strategy is based …

us (code pays fourni par la source)

3 citations Journal of Emergency and Critical Care Medicine
Accès ouvert 2022 article OpenAlex

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection

Scott Schoninger, Yanina Dubrovskaya, Kassandra L Marsh, Diana Altshuler et autres

Abstract Background Patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) have poor outcomes and frequently develop comorbid conditions, including cytomegalovirus (CMV) reactivation. The implications of CMV reactivation in this setting are unknown. We aimed to investigate if …

us (code pays fourni par la source)

9 citations Open Forum Infectious Diseases
Accès ouvert 2022 article OpenAlex

The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome

Alyson Katz, Diana Altshuler, John Papadopoulos, Nancy E. Amoroso et autres

Background: Corticosteroids and tocilizumab have been shown to improve survival in patients who require supplemental oxygen from coronavirus disease 2019 (COVID-19) pneumonia. The optimal dose of immunosuppression for the treatment of COVID-19 acute respiratory distress syndrome (ARDS) is still unknown. Objective: The …

us (code pays fourni par la source)

9 citations Annals of Pharmacotherapy
2022 article OpenAlex

Antithrombotic management for Impella ® temporary ventricular assist devices: An analysis of an academic health-system experience

Olivia Iskaros, Tania Ahuja, Serena Arnouk, Bridget Toy et autres

The use of acute mechanical circulatory support (MCS) has increased over the last decade. For patients with left-ventricular failure, an Impella ® (Abiomed, Danvers, MA) may be used to improve cardiac output. The purpose of this study is to describe Impella ® …

us (code pays fourni par la source)

5 citations The International Journal of Artificial Organs

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.